RE:RE:RE:RE:The Brazil contract is actually around $150 million for LABSOkay, lets normalize out of the equation Brazil as the revenue generator. Q1 2024 profitability is Mr. Pidduck's quantum leaps and assumptions and I'm only working from that along with the given financial data. We still need a contract of approximately $150 million for Q1 at approx 21% gross margins to generate a penny per share in earnings. Pidduck is leaving slices of bread not bread crumbs. "traditional global pharmceutical partner' and 'secrecy for competitive reasons'. Those two alone for me are a loaf of bread.
Time will tell the Truth π. It always does when you fully appreciate what the essence of 'time' is and it's origin.